Company profile
Nanobiotix
Building new therapies atom by atom.
- Industry
- Nanotechnology Research
- Employees
- 144
- Headquarters
- PARIS
- Founded
- 2003
- Office locations
- 1
Nanobiotix company summary
Nanobiotix is a company in the Nanotechnology Research industry, headquartered in PARIS, founded in 2003. On LinkedIn the company has around 144 employees. Its listed specialties include Nanomedicine, Pharma, Biotechnology, Oncology, Radiotherapy.
What technology does Nanobiotix use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Nanobiotix
Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanotherapeutics company pioneering new approaches to significantly improve patient outcomes for millions around the world by building new therapies atom by atom. The Nanobiotix philosophy is one rooted in designing pioneer physical-based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. The Nanobiotix global development strategy seeks to address the largest market in oncology—patients who receive radiotherapy as part of their treatment—with NBTXR3 (JNJ-1900). As the first product candidate from the company’s nanoradioenhancer platform, NBTXR3 aims to increase the tumor-killing effect of radiotherapy without increasing damage to surrounding healthy tissues and synergize with other anti-cancer therapies such as immune checkpoint inhibitors. Beyond NBTXR3, the Curadigm Nanoprimer Platform represents the second technology platform from Nanobiotix and the company’s next lever for growth. Curadigm's innovative approach seeks to improve treatment outcomes across several therapeutic classes by optimizing drug bioavailability and efficacy through systemic delivery enhancement. Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP) and on the Nasdaq Global Select Market (Nasdaq: NBTX). The Company’s headquarters are based in Paris, France, with a U.S. affiliate in Cambridge, MA. More: www.nanobiotix.com Read our Social Media Community Guidelines: https://nanobiotix.com/social-community-guidelines/
Specialties
Where is Nanobiotix located?
Nanobiotix lists 1 location.
Compare companies similar to Nanobiotix
More companies in Nanotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Nanobiotix nanobiotix.com | Nanotechnology Research | 144 | 2003 | PARIS |
 ZEISS Microscopy zeiss.com | Nanotechnology Research | 2,027 | 1846 | Jena, Thüringen |
| Nanotechnology Research | 502 | 2008 | Braga, Braga | |
 Quandela quandela.com | Nanotechnology Research | 163 | 2017 | Massy, Île-de-France |
 QuTech qutech.nl | Nanotechnology Research | 218 | 2014 | Delft, Zuid-Holland |
 Vesiculab vesiculab.com | Nanotechnology Research | 5 | - | Nottingham, Nottinghamshire |
 Nano One Materials Corp. TSX: NANO nanoone.ca | Nanotechnology Research | 81 | 2011 | Burnaby, BC |
 NoPo Nanotechnologies nopo.in | Nanotechnology Research | 54 | 2011 | Bangalore, Karnataka |
 Meta Materials Inc. (META®) metamaterial.com | Nanotechnology Research | 37 | 2011 | Halifax, Nova Scotia |
 NX Filtration nxfiltration.com | Nanotechnology Research | 140 | 2016 | Hengelo, Overijssel |
 LIGENTEC ligentec.com | Nanotechnology Research | 82 | 2016 | Ecublens, Vaud |
Frequently asked questions about Nanobiotix
What does Nanobiotix do?
Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanotherapeutics company pioneering new approaches to significantly improve patient outcomes for millions around the world by building new therapies atom by atom. The Nanobiotix philosophy is one rooted in designing pioneer physical-based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. The Nanobiotix global development strategy seeks to address the largest market in oncology—patients who receive radiotherapy as part of their treatment—with NBTXR3 (JNJ-1900). As the first product candidate from the company’s nanoradioenhancer platform, NBTXR3 aims to increase the tumor-killing effect of radiotherapy without increasing damage to surrounding healthy tissues and synergize with other anti-cancer therapies such as immune checkpoint inhibitors. Beyond NBTXR3, the Curadigm Nanoprimer Platform represents the second technology platform from Nanobiotix and the company’s next lever for growth. Curadigm's innovative approach seeks to improve treatment outcomes across several therapeutic classes by optimizing drug bioavailability and efficacy through systemic delivery enhancement. Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP) and on the Nasdaq Global Select Market (Nasdaq: NBTX). The Company’s headquarters are based in Paris, France, with a U.S. affiliate in Cambridge, MA. More: www.nanobiotix.com Read our Social Media Community Guidelines: https://nanobiotix.com/social-community-guidelines/
How many employees does Nanobiotix have?
Nanobiotix has around 144 employees on LinkedIn.
Where is Nanobiotix headquartered?
Nanobiotix is headquartered in PARIS.
When was Nanobiotix founded?
Nanobiotix was founded in 2003.
Build a lead list from companies like Nanobiotix
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.